Design for Peptide DeliverySM
- Assess drug delivery compatibility of a peptide
- Screen peptides for drug delivery
- Match peptide properties with proven
drug delivery technologies
- Launch products sooner by
decreasing development time
Proven drug delivery technologies are prefered for future products because these technologies have gone through the rigors of regulatory review, manufacturing, and market acceptance. To target proven drug delivery technologies, the SurModics Pharmaceuticals - Genzyme team performs drug-delivery-based preformulation screening on lead peptides in discovery. Additionally, the SurModics Pharmaceuticals - Genzyme team optimizes candidate peptides for long-acting parenteral delivery. <Click here for more details>
Events
BioPartnering North America
27 February - 1 March 2011
Vancouver, BC, Canada
BIO-Europe Spring
14-16 March 2011
Milan, Italy
ARVO
1-5 May 2011
Fort Lauderdale, FL
SurModics Booth 619
News
Webinar Archive: Screening Peptides for Extended Release
Genzyme Pharmaceuticals and SurModics Pharmaceuticals Enter Broad Collaboration
